{
    "clinical_study": {
        "@rank": "55237", 
        "arm_group": [
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "patients treated with placebo for at least 4 months before IVF attempt"
            }, 
            {
                "arm_group_label": "danazol", 
                "arm_group_type": "Active Comparator", 
                "description": "patients treated with danazol (100mg/day)for at least 4 months before IVF attempt"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether pre-treatment with danazol for at least 4\n      months before controlled ovarian hyperstimulation for IVF cycles improves pregnancy rate."
        }, 
        "brief_title": "Danazol Treatment in Endometriosis Women Before IVF", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Endometriosis", 
            "Ovarian Cysts", 
            "Infertility"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Endometriosis", 
                "Infertility", 
                "Ovarian Cysts"
            ]
        }, 
        "detailed_description": {
            "textblock": "Endometriosis is a chronic benign disease defined by the presence of endometrial tissue\n      outside the uterine cavity, affecting women in their reproductive age. This disease is\n      clinically characterized by infertility pelvic pain and the presence of ovarian cysts,\n      endometriomas, and affects the about 10% of women. Women with endometriosis when undergo IVF\n      show lower pregnancy rate than general population, and a reduced ovarian reserve, due to the\n      diseases and often to ovarian surgery. The aim of this study is to evaluate if a\n      pre-treatment with danazol, an anti-estrogenic agent, may improve the otcome of IVF cycles\n      in these women"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Clinical diagnosis of endometriosis previous laparoscopic surgery for ovarian\n        endometriotic cysts infertility\n\n        Exclusion Criteria:\n\n        - age more than 40 years systemic disease antimulleran hormone (AMH)<1 and FSH>20"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01779232", 
            "org_study_id": "CR-09-2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "danazol", 
                "description": "100 mg day for 4 monthh in women with diagnosed endometriosis before IVF", 
                "intervention_name": "Danazol", 
                "intervention_type": "Drug", 
                "other_name": "Danatrol"
            }, 
            {
                "arm_group_label": "control", 
                "description": "administered daily like the active comparator", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Danazol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "endometriosis", 
            "ivf", 
            "ovarian reserve", 
            "danazol"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "contact": {
                "email": "marcandrea@hotmail.com", 
                "last_name": "Marco Sbracia, MD", 
                "phone": "+393479037433"
            }, 
            "contact_backup": {
                "email": "quelidebercia@hotmail.com", 
                "last_name": "Daniela Marconi, MD", 
                "phone": "+39065810461"
            }, 
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00153"
                }, 
                "name": "CERM"
            }, 
            "investigator": {
                "last_name": "Fabio Scarpellini, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment With Danazol Before Controlled Ovarian Hyperstimulation in Women With Endometriosis Undergoing IVF", 
        "other_outcome": {
            "description": "number of mature oocyte collected for patient undergoing IVF", 
            "measure": "number of mature oocyte collected", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "overall_contact": {
            "email": "marcandrea@hotmail.com", 
            "last_name": "Marco Sbracia, MD", 
            "phone": "+393479037433"
        }, 
        "overall_contact_backup": {
            "email": "quelidebercia@hotmail.com", 
            "last_name": "Daniela Marconi, MD", 
            "phone": "+39065810461"
        }, 
        "overall_official": {
            "affiliation": "Centre for Endocrinology and Reproductive Medicine, Italy", 
            "last_name": "Marco Sbracia, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "number of ongoing pregnancy for the number of IVF cycles", 
            "measure": "pregnancy rate", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01779232"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre for Endocrinology and Reproductive Medicine, Italy", 
            "investigator_full_name": "Fabio Scarpellini", 
            "investigator_title": "Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "number of embryos implanted for the total number of embryos transferred", 
            "measure": "implantation rate", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Centre for Endocrinology and Reproductive Medicine, Italy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre for Endocrinology and Reproductive Medicine, Italy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}